Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic diagnosis using 5-ALA for biliary pancreatic cancer
jRCTs061210042Recruiting
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of 5-aminolevulinic acid in biliary cancer and pancreatic cancer (PC) (2 arms). Primary endpoint: Primary detection performance in biopsy tissue. Started Mar 2022; status: recruiting.
02
Drugs
5-aminolevulinic acid
03
Conditions
biliary cancerpancreatic cancer (PC)
Beyond the preview
Go deeper on jRCTs061210042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061210042.